Fever in Sepsis Revisited: Is a Little Heat What We Need? - Report - MDSpire

Fever in Sepsis Revisited: Is a Little Heat What We Need?

  • By

  • Alwin Tilanus

  • Wilmer Villamil

  • September 30, 2025

  • 0 min

Share

Clinical Report: Reassessing Fever in Sepsis: Is Mild Hyperthermia Beneficial?

Overview

Fever is a regulated increase in body temperature that enhances immune responses and inhibits microbial growth. Observational data suggest that lowering fever in septic patients may increase mortality, indicating potential benefits of mild hyperthermia in sepsis management.

Background

Fever results from a hypothalamic set point elevation mediated by pyrogenic cytokines in response to infection or other causes. This adaptive response stimulates both innate and adaptive immunity, including enhanced neutrophil activity, natural killer cell function, and antigen presentation. Most pathogens show inhibited growth at fever-range temperatures, which coincide with the human febrile range of 38°C to 41°C. Despite these benefits, fever is often treated aggressively due to concerns about metabolic demand and patient comfort.

Data Highlights

Observational studies have demonstrated that attempts to reduce fever in septic patients are associated with increased mortality. Experimental models show an inverse correlation between temperature and bacterial growth rates, such as Streptococcus pneumoniae and Haemophilus influenzae. In vitro data indicate improved susceptibility of bacteria to β-lactam antibiotics at fever-range temperatures.

Key Findings

  • Fever is a conserved adaptive response that optimizes innate and adaptive immune functions.
  • Fever-range temperatures inhibit growth of most mesophilic pathogens, aligning with the typical human fever range.
  • Pyrogenic cytokines such as IL-1, IL-6, and TNF mediate fever via prostaglandin E2 acting on the hypothalamus.
  • Observational studies link fever suppression in sepsis with increased mortality, suggesting fever may be protective.
  • Fever enhances antimicrobial efficacy, particularly improving β-lactam antibiotic susceptibility in vitro.
  • Both hypothermia and high-grade fever extremes in sepsis are associated with worse outcomes, highlighting the need for individualized temperature management.

Clinical Implications

Clinicians should reconsider routine antipyretic treatment in septic patients, as mild hyperthermia may confer immunological and antimicrobial advantages. Temperature management should be individualized, balancing metabolic demands and potential benefits of fever. Avoiding unnecessary fever suppression could improve sepsis outcomes.

Conclusion

Fever in sepsis represents a complex, evolutionarily conserved response that supports immune defense and microbial control. Emerging evidence suggests that mild hyperthermia may be beneficial, warranting cautious and individualized approaches to temperature management in septic patients.

References

  1. Global Health and Infectious Diseases, Review Article -- Reassessing Fever in Sepsis: Is Mild Hyperthermia Beneficial?

Original Source(s)

Related Content